These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 3229872)

  • 1. Effect of benazepril, a converting enzyme inhibitor, on plasma levels and activity of acenocoumarol and warfarin.
    Van Hecken A; De Lepeleire I; Verbesselt R; Arnout J; Angehrn J; Youngberg C; De Schepper PJ
    Int J Clin Pharmacol Res; 1988; 8(5):315-9. PubMed ID: 3229872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between international normalized ratio values, vitamin K-dependent clotting factor levels and in vivo prothrombin activation during the early and steady phases of oral anticoagulant treatment.
    D'Angelo A; Della Valle P; Crippa L; Fattorini A; Pattarini E; Viganò D'Angelo S
    Haematologica; 2002 Oct; 87(10):1074-80. PubMed ID: 12368163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Warfarin or acenocoumarol: which is better in the management of oral anticoagulants?
    Barcellona D; Vannini ML; Fenu L; Balestrieri C; Marongiu F
    Thromb Haemost; 1998 Dec; 80(6):899-902. PubMed ID: 9869157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship between maintenance dosages of three vitamin K antagonists: acenocoumarol, warfarin and phenprocoumon.
    van Leeuwen Y; Rosendaal FR; van der Meer FJ
    Thromb Res; 2008; 123(2):225-30. PubMed ID: 18407321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative study on the quality of oral anticoagulant therapy (warfarin versus acenocoumarol).
    Pattacini C; Manotti C; Pini M; Quintavalla R; Dettori AG
    Thromb Haemost; 1994 Feb; 71(2):188-91. PubMed ID: 8191397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CYP2C9 and oral anticoagulation therapy with acenocoumarol and warfarin: similarities yet differences.
    Takahashi H; Wilkinson GR; Padrini R; Echizen H
    Clin Pharmacol Ther; 2004 May; 75(5):376-80. PubMed ID: 15116049
    [No Abstract]   [Full Text] [Related]  

  • 7. Computation of unbound anticoagulant values in plasma.
    Wosilait WD; Garten S
    Res Commun Chem Pathol Pharmacol; 1972 Mar; 3(2):285-91. PubMed ID: 4139740
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of pulmonary embolism. I. Treatment with heparin and oral anticoagulants].
    Niewiarowski T; Filipecki S
    Pneumonol Pol; 1984 Sep; 52(9):447-52. PubMed ID: 6085154
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of montelukast on the pharmacokinetics and pharmacodynamics of warfarin in healthy volunteers.
    Van Hecken A; Depré M; Verbesselt R; Wynants K; De Lepeleire I; Arnout J; Wong PH; Freeman A; Holland S; Gertz B; De Schepper PJ
    J Clin Pharmacol; 1999 May; 39(5):495-500. PubMed ID: 10234597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of acenocoumarol on hemorheological parameters.
    Vayá A; Martínez M; Fernández A; Ripoll F; Moscardó F; Mira Y; Aznar J
    Clin Hemorheol Microcirc; 2001; 24(2):111-5. PubMed ID: 11381186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fatal intoxications by acenocoumarol, phenprocoumon and warfarin: method validation in blood using the total error approach.
    Denooz R; Douamba Z; Charlier C
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Aug; 877(23):2344-8. PubMed ID: 19144578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. International Normalized Ratio (INR) increase in patients taking oral anticoagulant therapy (OAT) and using sildenafil (Viagra).
    Fernández MA; Romá E
    Haematologica; 2003 Dec; 88(12):ELT34. PubMed ID: 14688013
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of different angiotensin converting enzyme inhibitors on coronary collateral circulation].
    Zhang XH; Ma XJ; Luo J; Shao JH; Geng QX; Zhu XL; Tang YS; Xu FY
    Zhonghua Yi Xue Za Zhi; 2004 Apr; 84(7):592-5. PubMed ID: 15144597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Laboratory and therapeutic control of oral anticoagulant treatment].
    Salvetti E; Molinatti M
    Ann Osp Maria Vittoria Torino; 1987-1988; 30():67-71. PubMed ID: 3508666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low dose oral vitamin K to reverse acenocoumarol-induced coagulopathy: a randomized controlled trial.
    Ageno W; Crowther M; Steidl L; Ultori C; Mera V; Dentali F; Squizzato A; Marchesi C; Venco A
    Thromb Haemost; 2002 Jul; 88(1):48-51. PubMed ID: 12152676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of nateglinide on the pharmacokinetics and pharmacodynamics of acenocoumarol.
    Sunkara G; Bigler H; Wang Y; Smith H; Prasad P; McLeod J; Ligueros-Saylan M
    Curr Med Res Opin; 2004 Jan; 20(1):41-8. PubMed ID: 14741071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of evening versus morning benazepril on 24-hour blood pressure: a comparative study with continuous intraarterial monitoring.
    Palatini P; Mos L; Motolese M; Mormino P; Del Torre M; Varotto L; Pavan E; Pessina AC
    Int J Clin Pharmacol Ther Toxicol; 1993 Jun; 31(6):295-300. PubMed ID: 8335427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in plasma warfarin levels and variations in steady-state prothrombin times.
    White RH; Zhou H; Romano P; Mungall D
    Clin Pharmacol Ther; 1995 Nov; 58(5):588-93. PubMed ID: 7586953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative study of the stability of oral anticoagulant treatments (warfarin vs acenocoumarol)].
    Amián A; Rodríguez JN; Muñiz R; Diéguez JC; Moreno MV; Quesada JA; Cañavate M; Fernández-Jurado A; Martino ML; Prados D
    Sangre (Barc); 1996 Feb; 41(1):9-11. PubMed ID: 8779047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of patient capability to self-adjust oral anticoagulant dose: a multicenter study on home use of portable prothrombin time monitor (COAGUCHECK).
    Cosmi B; Palareti G; Carpanedo M; Pengo V; Biasiolo A; Rampazzo P; Morstabilini G; Testa S
    Haematologica; 2000 Aug; 85(8):826-31. PubMed ID: 10942929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.